Larvol Delta - AmMax-Bio-Announces-First-Patient-Enrolled-in-Phase-2-Trial-of-AMB05X-For-Tenosynovial-Giant-Cell-Tumor-TGCT

AMB-051 - AmMax

https://www.globenewswire.com/news-release/2021/05/26/2236326/0/en/AmMax-Bio-Announces-First-Patient-Enrolled-in-Phase-2-Trial-of-AMB-05X-For-Tenosynovial-Giant-Cell-Tumor-TGCT.html

May 26, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next